Joint with: Fibrosis: Cross Organ Pathology and Pathways to Clinical Development
Stromal Immunology in Health and Disease

Feb 02–05, 2026 | Fairmont Banff Springs, Banff, AB, Canada
Scientific Organizers: Anne Fletcher, Sanjiv A. Luther, Viviana Cremasco and Michael B. Brenner

  In Person
  On Demand
 Add to Calendar

Feb 02–05, 2026 | Fairmont Banff Springs, Banff, AB, Canada
Scientific Organizers: Anne Fletcher, Sanjiv A. Luther, Viviana Cremasco and Michael B. Brenner

Supported by the  Directors' Fund

***Meeting program subject to change.

Available Formats:   = In Person     = On Demand
Monday, February 2, 2026
Registration
4:00–8:00 PM
 Van Horne Foyer
Welcome Mixer
6:00–8:00 PM
 Van Horne Foyer
Tuesday, February 3, 2026
Breakfast
7:00–8:00 AM
 President's Hall
Welcome and Keynote Address (Joint)
8:00–9:00 AM
 Van Horne A/B
Thomas A Wynn, Pfizer
The Future of Anti-Fibrotic Therapy: Scar Macs and Beyond
From Fibroblasts to Fibrosis, and Back Again (Joint)
9:00–11:15 AM
 Van Horne A/B
Boris Hinz, St. Michael's Hospital and University of Toronto
To Push or Pull? How the Mechanical Environment Affects Stromal Activation
Sheila A. Stewart, Washington University School of Medicine
Stromal Reprogramming Sensitizes Metastatic Breast Cancer to Immunotherapy
Michael B. Brenner, Harvard Medical School
Regulators of Fibroblast Inflammation, Tissue Degradation and Fibrosis
Short Talk(s) Chosen from Abstracts
Coffee Break
9:30–9:50 AM
 Van Horne Foyer
Poster Setup
11:15–1:00 PM
 Van Horne C
On Own for Lunch
11:15–2:30 PM
Poster Viewing
1:00–10:00 PM
 Van Horne C
Symposia Spotlight 1: Late Breaking News
2:30–4:30 PM
 Van Horne B
Short Talk(s) Chosen from Abstracts
Coffee Available
4:30–5:00 PM
 Van Horne Foyer
Stromal Development, Identity and Heterogeneity
5:00–7:00 PM
 Van Horne B
Sanjiv A. Luther, University of Lausanne
Mechanisms of Fibroblast Specialization and Lymphoid Organ Compartmentalization
Sophie E. Acton, University College London
The Molecular Function of PDPN
Anne Fletcher, Monash University
Molecular Drivers of Fibroblast Differentiation and T Cell Suppression
Short Talk(s) Chosen from Abstracts
Social Hour with Dinner
7:00–8:00 PM
 President's Hall
Posters
7:30–10:00 PM
 Van Horne C
Wednesday, February 4, 2026
Breakfast
7:00–8:00 AM
 President's Hall
Stromal Responses to Inflammation: The Good, The Bad, The Ugly
8:00–11:00 AM
 Van Horne B
Ari B Molofsky, University of California San Francisco
Stromal – Immune Tissue Niches in Health and Disease
Natalia Pikor, ETH Zurich / Kantonsspital St.Gallen
Fibroblast - Immune Cell Crosstalk in the Inflamed CNS
Mariapia A. Degli-Esposti, Monash University
Viral Targeting of Lymphoid Fibroblasts Yields Immunological Outcomes
Tatiana V. Petrova, CHUV, University of Lausanne
Mechanosensitive mTORC1 Signaling Maintains Lymphatic Valves
Short Talk(s) Chosen from Abstracts
Coffee Break
9:00–9:20 AM
 Van Horne Foyer
Poster Setup
11:00–1:00 PM
 Van Horne C
On Own for Lunch
11:00–1:30 PM
Poster Viewing
1:00–10:00 PM
 Van Horne C
Symposia Spotlight 2: New Technologies in Stromal Cell Research
1:30–3:15 PM
 Van Horne B
Short Talk(s) Chosen from Abstracts
Career Roundtable (Joint)
3:30–4:30 PM
 Van Horne B
Coffee Available
4:30–5:00 PM
 Van Horne Foyer
The Pathogenic Tumor Microenvironment
5:00–7:00 PM
 Van Horne B
Ruth Scherz-Shouval, Weizmann Institute of Science
Hierarchy of Tumor Cell-Cell Signaling Interactions Dominated by Fibroblasts
Michael J Briskin, Phenomic.AI
scRNA Analysis at Scale Identifies CTHRC1 as a Novel Tumor-Stroma Target
Fatima Mechta-Grigoriou, Institut Curie
Stromal Spatial Transcriptomics and Therapy Resistance in Metastatic Breast Cancer
Short Talk(s) Chosen from Abstracts
Social Hour with Dinner
7:00–8:00 PM
 President's Hall
Posters
7:30–10:00 PM
 Van Horne C
Thursday, February 5, 2026
Breakfast
7:00–8:00 AM
 President's Hall
Molecular Mechanisms of Stromal Programming and Reprogramming
8:00–11:00 AM
 Van Horne B
Beth A. Tamburini, University of Colorado Denver Anchutz Medical Campus
Lymph Node Stromal Cell Mechanisms of Immune Regulation
Marc Bajénoff, Centre d'Immunologie Marseille-Luminy
Macrophage-Fibroblast Interaction Modules
Michael Sixt, Institute of Science and Technology Austria
Fibroblast-Leukocyte Morphodynamics
George A. Kollias, Biomedical Sciences Research Center 'Alexander Fleming'
'Fibroblasts Transitioning from Homeostasis to Inflammation to Fibrosis
Short Talk(s) Chosen from Abstracts
Coffee Break
9:00–9:20 AM
 Van Horne Foyer
On Own for Lunch
11:00–2:30 PM
Symposia Spotlight 3: Stromal Commonalities and Nomenclature
2:30–4:30 PM
 Van Horne B
Short Talk(s) Chosen from Abstracts
Coffee Available
4:30–5:00 PM
 Van Horne Foyer
Therapeutic Modulation of Stromal Cell Function (Joint)
5:00–6:45 PM
 Van Horne A/B
Viviana Cremasco, Novartis Biomedical Research
TGFb Neutralization and Tumor Stroma Modulation: From Bench to Bed
Yuval Rinkevich, Helmholtz Zentrum München, GmbH
Regenerative Medicine and Tissue Repair
Burkhard Ludewig, Kantonsspital St. Gallen
Immunomodulation of Myocardial Fibrosis
Short Talk(s) Chosen from Abstracts
Meeting Wrap-Up: Outcomes and Future Directions (Organizers) (Joint)
6:45–7:00 PM
 Van Horne A/B
Social Hour with Dinner
7:00–8:00 PM
 President's Hall
Entertainment
8:00–11:00 PM
Cash Bar
8:00–11:00 PM
Friday, February 6, 2026
Departure
12:00–11:59 PM

Subscribe for Updates